Insider Trading & Ownership - Evans Carl Anthony

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Evans Carl Anthony
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-01
Purchase
2024-02-06
10:27 am
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
33,333$0.3$10,000224,313
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-08
Option Award
2024-04-10
9:52 pm
N/A
2034-04-08
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
35,000$0276,688
(Direct)
View
2024-02-01
Option Award
2024-02-06
10:27 am
2024-02-01
2029-02-01
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
66,666$0224,313
(Direct)
View
2023-09-21
Option Award(A)
2023-10-12
6:01 pm
N/A
2033-09-22
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
39,475$045,428
(Direct)
View
2023-09-21
Option Award
2023-09-25
6:24 pm
N/A
2033-09-22
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
68,961$074,914
(Direct)
View
2022-03-08
Option Award
2022-03-09
2:34 pm
N/A
N/A
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
3,750$0.2683,750
(Direct)
View
2021-07-15
Option Award
2021-07-16
5:00 pm
N/A
2031-07-15
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
32,000$0178,559
(Direct)
View
2020-06-12
Option Award
2020-06-16
5:23 pm
N/A
2030-06-12
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
46,559$0146,559
(Direct)
View

Ownership
2019-11-08
5:26 pm
N/A
2028-07-09
CNS Pharmaceuticals Inc.CNSPEvans Carl Anthony
Director
0$0100,000
(Direct)
View
(A) Indicate amendment filing.